Know How Tresiba Stacks Up Against Other Long-Acting Insulins

November 2017

A new long-acting insulin, Tresiba (treh-SEE-bah, insulin degludec), is hitting pharmacy shelves.

Think of Tresiba as similar to Lantus (insulin glargine) and other "basal" insulins (Levemir, Toujeo, etc).

They all work to lower blood sugar throughout the day.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Emergency Preparedness Assist Your Patients During a Disaster
Medication Errors Renew Your Efforts to Prevent Common Med Errors
Insulin Know How Tresiba Stacks Up Against Other Long-Acting Insulins
Recalls Ensure Your Patients Don't Get Recalled Meds
Hazardous Meds Use Strategies to Minimize Exposure to Oral Chemotherapy Drugs
Med Administration Don't Be Surprised to See Inhaled Steroids With Sigs to "Swallow"
Interactions Expect Oral Meds to Be Taken 3 Hours Before or After Potassium Binders
Cholesterol Take Steps to Improve Patient Adherence to Statins
Pregnancy Help With Safe Opioid Use in Pregnant Patients
Kidney Disease Help Chronic Kidney Disease Patients Reduce Itching